A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Clinical trial NCT07409103 · RECRUITING
Trial details
- NCT number
- NCT07409103
- Sponsor
- Elevara Medicines Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-18
- Primary completion
- 2027-04-15
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.